Linda S. Marton

Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system

Abstract: The oligodendrocyte‐myelin glycoprotein (OMgp) is a 110‐kDa glycosylphosphatidylinositol‐linked protein that was initially identified as a myelin‐specific protein but whose precise function remains unknown. In this study, immunohistochemistry, western blots, in situ hybridization, and northern blots were used to determine the distribution of OMgp in the mouse brain. OMgp is present in a concentration detectable on western blots in the brains of newborn mice, and its concentration gradually increases until day 24 of life. OMgp mRNA is also present in amounts detectable on northern blots in the brains of newborn mice, and its concentration gradually increases until day 21 of life, after which the concentration diminishes a little. Most of the OMgp in the mouse brain appears to be expressed in diverse groups of neurons, but it is particularly prominent in large projection neurons such as the pyramidal cells of the hippocampus, the Purkinje cells of the cerebellum, motoneurons in the brainstem, and anterior horn cells of the spinal cord. However, OMgp is not confined to these cells and is expressed in cells in the white matter as well. The OMgp gene is placed within an intron of the neurofibromatosis type I gene and on the opposite strand. This organization raises the possibility that there may be a relationship between the functions of the products of the two genes. In support of this possibility, we show that within the mouse CNS OMgp and neurofibromin are expressed in the same cell types.

Immunohistochemistry of Retinoblastomas in Humans

We examined immunohistochemically the distribution of the neuronal-specific protein enolase (14-3-2) in normal human retina. We also examined the distribution of neuronal-specific enolase, glial fibrillary acidic protein, myelin-associated glycoprotein, and S-100 protein in seven human retinoblastomas. In normal retina neuronal-specific enolase was present in neurons but not in other cell types. The inner segments of cones stained darkly with antiserum to neuronal-specific enolase; the inner segments of rods stained either weakly or not at all. Most small round cells in all seven retinoblastomas studied stained with antiserum to neuronal-specific enolase but Flexner-Wintersteiner rosettes stained weakly or not at all. One retinoblastoma contained an area of cells that stained with antibodies to myelin-associated glycoprotein which in normal retina is found only in Müllers cells. Another retinoblastoma had an area of cells that stained with antiserum to glial fibrillary acidic protein, which in normal human retina is present only in astrocytes. All seven retinoblastomas lacked detectable S-100 protein. These results supported the conventional view that retinoblastomas are neuronal tumors although some may contain areas that show astrocytic or Müllers cell differentiation.

Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys.

Hemoglobin is a key factor in the production of cerebral vasospasm. Metabolism of hemoglobin involves breakdown of heme by heme oxygenase (HO) and sequestration of the released iron in ferritin. We determined whether subarachnoid hemorrhage induces these proteins in cerebral arteries and, if so, in which cells they are produced. Whether the changes correlated with vasospasm also was investigated. Subarachnoid hemorrhage was created in monkeys, and vasospasm was assessed by angiography in cohorts of animals killed 3, 7, or 14 days after the hemorrhage. Ferritin and HO-1 messenger ribonucleic acid (mRNA) and protein were measured by competitive reverse transcription-polymerase chain reaction and Western blotting in hemorrhage-side and control-side cerebral arteries and brain tissue. The location of these proteins was determined by immunohistochemistry. There was significant vasospasm 3 and 7 days but not 14 days after subarachnoid hemorrhage. There were no significant changes in mRNA for HO-1 or ferritin in cerebral arteries or brain tissue at any time. There was a significant increase in HO-1 and ferritin protein in hemorrhage-side compared with control-side cerebral arteries at 3, 7, and 14 days. The increase in HO-1 protein was maximal at 3 days, whereas the increase in ferritin protein was maximal at 7 days. There was no detectable increase in HO-1 or ferritin protein in brain tissue at any time. Immunohistochemistry localized HO-1 protein and ferritin to cells in the adventitia of the arterial wall. We show that subarachnoid hemorrhage is associated with a significant increase in HO-1 and ferritin proteins in cerebral arteries that begins at least as early as 3 days after the hemorrhage and that persists for up to 14 days.

Distribution of S-100 protein and glial fibrillary acidic protein in normal and gliotic human retina.

Monoclonal antibodies and polyclonal antisera were used to examine the distribution of S-100 protein in human retinas both immunohistochemically and immunochemically and to compare it to that of glial fibrillary acidic protein (GFAP). S-100 was not found in normal retinas nor in retinas with areas of reactive gliosis. GFAP was found in perikarya and processes of cells the nuclei of which were in the nerve fiber layer of normal retina. In areas of reactive gliosis there was intense staining with antiserum against GFAP extending from the internal limiting membrane to the external limiting membrane. Some of the glial cells in human retina and fibrillary astrocytes in the brain are identical in their expression of GFAP. However, absence of S-100 from both quiescent and reactive retinoglia distinguishes them from astrocytes in brain and spinal cord.

Vasospasm in Monkeys Resolves Because of Loss of and Encasement of Subarachnoid Blood Clot

Background and Purpose— We studied in monkeys why vasospasm resolves after subarachnoid hemorrhage (SAH). Methods— Monkeys underwent angiography and right (n=17) or bilateral (n=8) SAH. Animals with bilateral SAH underwent angiography 1, 3, 5, and 7 days later. Animals with right SAH underwent angiography 7 days later. The clot was then not removed (n=5), removed and replaced with fresh clot (n=7), or removed and not replaced (n=5). At the same time on day 7, the removed clot (n=12) or fresh clot (n=5) was placed on the left side. Angiography was repeated every 2 days until day 14. Results— SAH caused significant vasospasm on day 7 that resolved by day 14. Removal of clot on day 7 resulted in more rapid resolution of vasospasm. Placement of fresh clot onto arteries that had already been exposed to clot for 7 days produced vasospasm that persisted without resolving for an additional 7 days. Placement of 7-day-old clot from the right onto previously unexposed left arteries or of clot from blood removed from an animal 7 days after SAH caused significantly more rapid onset of vasospasm compared with de novo vasospasm. Microscopic examination of the clots showed they were surrounded by macrophages 7 days after SAH. Arterial compliance and contractility were reduced in relation to duration of the exposure of arteries to clot. Conclusions— Vasospasm resolves because of loss of subarachnoid blood clot. We hypothesize that reduced spasmogen release from the clot contributes to resolution of vasospasm. There was no response in the cerebral arteries that rendered them less responsive to the subarachnoid clot.

Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study

Alz-50 is a monoclonal antibody raised against ventral forebrain tissue from patients with Alzheimers disease (AD). It was originally believed that the antigen recognized by Alz-50 was only found in degenerating neurons. However, recent studies indicate that Alz-50 stains neurons in a limited but specific distribution in normal brains throughout life. As the antigen recognized by Alz-50 in normal brains may give some insight into the AD degenerative process, we characterized Alz-50 staining in the normal ovine striatum using immunoblots and immunocytochemistry at the light and electron microscope levels. We then compared the Alz-50 staining pattern with those of NADPH diaphorase histochemistry and immunocytochemistry using antisera against several neuropeptides, Alzheimer-related proteins, and heat-shock proteins. Western blot analysis indicated that the epitope recognized by Alz-50 in the normal sheep brain is on the microtubule-associated protein tau, and preadsorbing Alz-50 with a peptide corresponding to the amino terminus of the tau molecule eliminated staining. Alz-50 labeled a single population of cells in the ovine striatum, the medium aspiny neurons. At the light microscope level, the granular staining pattern closely resembled Alz-50 immunoreactive neurons in the normal human striatum and in cells undergoing early degeneration in AD. Alz-50 immunoreactive neurons stained immunocytochemically with antisera against somatostatin, neuropeptide Y, and histochemically for NADPH diaphorase. These cells were morphologically characterized by smooth dendrites, elaborate local axonal plexuses, and indented nuclei with filamentous inclusions. Ultrastructurally, Alz-50 immunodecorated ribosomes and membranous structures (e.g. vesicles, endoplasmic reticulum), and many boutons which contained Alz-50-positive synaptic vesicles. None of the antisera against other Alzheimer-related proteins, including paired helical filament protein, ubiquitin, beta-amyloid protein, or heat-shock proteins specifically stained the population of cells labelled by Alz-50. Other tau antisera also did not specifically stain these cells. We conclude that Alz-50 recognizes an amino terminal epitope that is exposed on tau proteins within a single, discrete population of neurons in the normal sheep striatum. The presence of this epitope in a normal cell population raises the possibility that the early stages of AD degeneration may involve the activation of a normal cellular pathway that modifies the tau molecule.

The Vasorelaxation of Cerebral Arteries by Carbon Monoxide

Carbon monoxide (CO) is known to increase cerebral blood flow, but the effect of CO on the vascular tone of large cerebral arteries is uncertain. We tested whether CO affects cerebral artery tone by measuring tension generated by ex vivo segments of dog basilar artery upon exposure to CO. In cerebral artery segments contracted with either KCI or prostaglandin F2a, CO caused a concentration-related relaxation beginning with a concentration of 57 μM. Relaxation did not occur if CO was administered in the presence of bubbling carboxygen (95% 02:5% CO2), which reduces greater than 99% of CO from the solution. Furthermore, the CO-induced relaxation of cerebral artery segments was reduced in the presence of the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 μM)or the potassium channel blocker tetraethylammonium (TEA, 1 mM). Neither ODQ nor TEA completely eliminated the relaxation caused by CO and there was no additive effect if ODQ and TEA were administered together. These results suggest that cerebral arteries are directly relaxed by CO and that this relaxation depends upon the activation of guanylyl cyclase and the opening of potassium channels.

Tyrosine phosphorylation and [Ca2+]i elevation induced by hemolysate in bovine endothelial cells: implications for cerebral vasospasm.

Endothelial cells are affected in the cerebral vasospasm that occurs at the time of erthyrocyte lysis in a subarachnoid clot. A red blood cell lysate was added to bovine pulmonary artery endothelial cells in vitro to determine whether hemolysate can trigger tyrosine kinase mediated cell signalling and if so, whether this signal is independent of the elevation of intracellular free calcium levels, [Ca2+]i induced by hemolysate. Hemolysate was found by Western blotting to induce a dose dependent increase in the level of tyrosine phosphorylation of two proteins, approximately 60 and 110 kD, that was maximal between 1 and 2 min. The biphasic increase in [Ca2+]i induced by hemolysate consists of a peak complete within 1 min which is the result of release of intracellular calcium stores and a plateau phase due to an influx of extracellular Ca2+. Addition of hemolysate to cells in the presence of EGTA indicated that an extracellular Ca2+ influx is not required for the increases in tyrosine phosphorylation. Release of intracellular Ca2+ stores by thapsigargin, a Ca(2+)-ATPase inhibitor, was, however, found to increase the phosphotyrosine content of the same 60 and 110 kD proteins. Endothelial cells pretreated with tyrosine kinase inhibitors, tyrphostin 25 or genistein, before exposure to hemolysate blocked the plateau phase of the [Ca2+]i response indicating that tyrosine kinase activity is required for the influx. Ca2+ and phosphotyrosine mediated cell signalling induced by hemolysate in endothelial cells may be activated by a single component but represent distinct targets for possible control of the cerebral vasospasm response.

Hemolysate inhibits L-type Ca2+ channels in rat basilar smooth muscle cells

Erythrocyte lysate increases intracellular Ca2+ ([Ca2+]i) and contracts cerebral arteries in vitro and has been suggested to be the cause for cerebral vasospasm. We investigated the effect of hemolysate on L-type Ca2+ channels directly by using patch clamp techniques in freshly isolated single smooth muscle cells from rat basilar artery. Patch clamp studies revealed a whole-cell current which resembles the L-type Ca2+ current reported by others. Hemolysate reduced the amplitude of the L-type Ca2+ channel current. The effect of hemolysate was reversible by washout and repeatable. Hemolysate was separated into two fractions by using filter membranes. The fraction > 1 kDa which contains oxyhemoglobin and other proteins mimicked the effect of hemolysate, while the fraction < 1 kDa and ATP were without effect. We conclude that hemolysate does not increase [Ca2+]i by activation of L-type Ca2+ channel.

U74389G Prevents Vasospasm after Subarachnoid Hemorrhage in Dogs

OBJECTIVE Oxygen-derived free radicals may contribute to vasospasm after the rupture of an intracranial aneurysm through direct vasoconstricting effects occurring within the arterial wall or, secondarily, by causing lipid peroxidation in the subarachnoid erythrocytes with secondary induction of vasoconstriction. U74389G is a potent inhibitor of lipid peroxidation and a scavenger of oxygen-derived free radicals. This study determined the relative contributions of oxygen-derived free radicals and lipid peroxidation to vasospasm in the double-hemorrhage dog model. METHODS Sixteen dogs underwent baseline (Day 0) cerebral angiography and induction of subarachnoid hemorrhage by two injections of blood into the cisterna magna 2 days apart. They were randomized to receive drug vehicle (n=8) or U74389G (n=8, 3 mg/kg of body weight/d) intravenously. Drug administration and end point analysis were blinded. The end points were angiographic vasospasm, as assessed by comparison of angiograms obtained before and 7 days after subarachnoid hemorrhage, and the levels of malondialdehyde and salicylate hydroxylation products (dihydroxybenzoic acids) in cerebrospinal fluid and of malondialdehyde in subarachnoid blood clots and basilar arteries 7 days after hemorrhage. RESULTS Comparisons within groups of Day 0 and Day 7 angiograms and between groups of angiograms obtained at Day 7, showed significant vasospasm in animals in the vehicle group (mean+/-standard error, 51%+/-4) but not in the U74389G group (25%+/-11, P < 0.05, unpaired t test). High-pressure liquid chromatographic assays of malondialdehyde and dihydroxybenzoic acids in cerebrospinal fluid, subarachnoid blood clots, and basilar arteries showed no significant differences between groups. CONCLUSION The significant prevention of vasospasm by U74389G without change in levels of indicators of free radical reactions suggests that the effect of the drug is related to other processes occurring in the arterial wall and that cerebrospinal fluid levels of oxygen radicals and lipid peroxides are not useful markers of vasospasm.